Powerpoint 4 Chapter 14 Flashcards

(68 cards)

1
Q

epinephrine receptor

A

beta-andrenergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

epinephrine causes

A

energy-store mobilization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

insulin causes

A

increased glucose uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

EGF causes

A

expression of growth-promoting genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

signal transduction steps

A

1) release of primary messenger 2) reception of primary messenger 3) transduction. receptor releases second messengers 4) Activation of effectors 5) termination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

effector

A

controls channels or pumps, enzymes, or proteins that control gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

common second messengers

A

cAMP, Ca++, inositol, DAG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

three receptor types of signalling pathways

A

G-protein coupled, enzyme linked, ligand gated ion channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

enzyme linked receptors have ? or ? activity

A

cytoplasmic tyrosine kinase, guanylyl cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

G-protein receptors AKA

A

7-transmembrane helix receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

7TM receptors only found in ?

A

eukaryotes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

first member of the 7TM family discovered

A

Rhodopsin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

?% of therapeutic drugs target 7TM receptors

A

50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

bind to andrenergic receptors to activate

A

agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

inhibit actvation

A

antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

types of andrenergic receptors

A

alpha 1 and 2, beta 1,2 and 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

consequence of ligand binding to 7TM

A

conformational change converts receptor into a guanine nucleotide exchange factor. activation of G protein trimer (of alpha, beta, and gamma subunits) because the alpha subunit binds guanyl nucleotides causes the alpha subunit to dissociate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

activation of adenylate cyclase by alpha subunit of G-protein causes

A

conversion of ATP into cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

beta-andrenergic receptor is a type of ?

A

7TM receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

epinephrine binding to beta-andrenergic receptor resulting pathway

A

activation, conformatinal change. activation of G-protein and dissociation of alpha subunit. protein interaction with adenylate cyclase activates. enzymatic reaction to form cAMP. activated protein kinase A.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

pathway linking activated Protein Kinase A to mobilization of stored CHO

A

PKA activates phosphoryl kinase. phosphoryl kinase activates phosphorylase. phosphorylase initiates synthesis of glucose from glycogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

four ways of regulating signaling

A

at the receptor (agonist/antagonist, desensitization), the g-protein itself, second messenger, protein kinases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

receptors turned of by?

A

dissociation of signal molecule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

receptors desensitized by?

A

phosphorylation of cytoplasmic C-terminal and binding of b-arrestin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
G-proteins are timers because..
they turn off by hydrolyzing GTP to GDP and Pi
26
cAMP is degraded by
soluble phosphodiesterase
27
ACE inhibitors are important for?
lowering blood pressure
28
ACE stands for
angiotensin converting enzyme
29
angiotensin is produced by ACE and causes
vasoconstriction by activating a G-protein that activates Phospholipase C
30
signaling via phospholipase C releases these two secondary messengers from cleavage of PIP2
IP3, DAG
31
Protein kinase C can be artificially activated by addition of ?
phorbol esters that bind to DAG site and a calcium ionophore
32
IP3 causes
rapid release of Ca++
33
PKC ordinarily activated by ?
DAG
34
fertilization of an egg causes a wave of ? in the cytoplasm. It can be monitored by fluorescence.
Ca++
35
common Ca++ binding site
EF Hand motif
36
two important Ca++ binding proteins
calmodulin and annexins
37
calmodulin activation causes
exposing of hydrophobic patches that bind target proteins. ex. activation of CaM kinase
38
CaM kinase function
phosphorylates target proteins that regulate metabolism, ion permeability, and neurotransmitter release
39
common signals of enzyme linked receptors
insulin, EGF
40
insulin receptor structure
dimer of alpha-beta subunits. insulin binding site is between the two alpha subunits outside of cell
41
result of insulin binding to insulin receptor
autophosphorylation followed by phosphorylation of target proteins such as insulin receptor substrates
42
the insulin receptor is a ? kinase
tyrosine
43
the insulin receptor substrates share (3)
pleckstrin domain, SH2 domains, four Tyr phosphorylation sites
44
pleckstrin domain function
binds PIP2
45
SH2 domain function
binds phosphotyrosine
46
Akt-2, activated by insulin receptor phosphorylation cascade, is a protein kinase that ?
stimulates fusion of GLUT4 receptor vesicles to plasma membrane
47
phosphotyrosine of IRS-1 recruits ?
cytosolic PI3 kinase
48
? domain of PI3 kinase binds to IRS-1
SH2
49
binding of PI3 kinase to IRS-1 allows ?
it to interact with its membrane substrate
50
PI3 kinase produces the secondary messenger ?
PIP3
51
phosphatases ? and ? convert PIP3 back to PIP2
PTEN and SHIP
52
insulin signaling pathway
activated receptor. phosphorylated IRS proteins. localized PI3 kinase. production of PIP3. activated PIP3 dependent protein kinase. activated Akt protein kinase. increased glucose transporter on cell surface.
53
? removes activated receptor
receptor recycling
54
Akt is dephosphorylated by ?
PHLPP
55
EGF binding to its monomeric receptor causes
a conformatinal change that leads to dimerization
56
dimerization of EGF receptor activates ?
autophosphorylation of tyrosines in the c-terminal tail
57
phosphotyrosine tails of EGF receptor recruit ?
adaptor proteins like Grb-2
58
SH3 domain of Grb-2 binds to ?
proline-rich portions of the protein SOS
59
SOS
guanine nucleotide exchange factor protein that activates a small G protein called Ras
60
Ras initiates ?
phosphorylation cascade by activation of Raf
61
oncogene
leads to cancerlike characteristics in susceptible cell types
62
c-Src vs v-Src
c-Src contains key tyrosine residue near its C-terminal that when phosphorylated binds to upsteam SH2 region. v-Src lacks this and can not be turned off and leads to unregulated cell growth.
63
? mutations are the most common mutations in tumors
Ras
64
overexpression of EGF receptor leads to ?
dimerization in the absence of EGF
65
? block dimerization of EGF receptor
monoclonal antibodies
66
SH2 and SH3 domains of Src work together to inhibit
tyrosine kinase activity
67
90% of patients with chronic myelogenous leukemia have a chromosomal defect that ?
activates a tyrosine kinase bcr-abl
68
? is an effective treatment for chronic myelogenous leukemia
gleevec